Peter Sorger, the Krayer professor of systems pharmacology at HMS and head of the new Harvard Program in Therapeutic Science, will lead the new HMS program that aims to use multidisciplinary approaches from systems biology to create a more rational basis for drug development. Joseph Loscalzo, the Hersey Professor of the Theory and Practice of Physic and chair of the Department of Medicine at Brigham and Women’s Hospital, is also quoted.
